Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 11.45
+0.22 (1.96%)
Jun 9, 2026, 3:10 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 18.31 billion as of June 9, 2026. Its market cap has increased by 10.74% in one year.
Market Cap
18.31B
Enterprise Value
19.11B
Revenue
2.40B
Ranking
n/a
PE Ratio
64.53
Stock Price
11.45
Market Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 18.31B, an increase of 34.31%. That is a compound annual growth rate of 1.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 17.96B | 2.93% |
| Dec 31, 2025 | 17.45B | -9.69% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangmei Pharmaceutical | 20.88B |
| Betta Pharmaceuticals | 20.57B |
| Jilin Aodong Pharmaceutical Group | 19.90B |
| Chengdu Kanghong Pharmaceutical Group | 19.65B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 19.62B |
| Hybio Pharmaceutical | 18.96B |
| Guangdong Zhongsheng Pharmaceutical | 18.59B |
| Dizal (Jiangsu) Pharmaceutical | 18.37B |